Literature DB >> 11477144

Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation.

A Marchio1, B Terris, M Meddeb, P Pineau, A Duverger, P Tiollais, A Bernheim, A Dejean.   

Abstract

BACKGROUND/AIM: The pathogenetic relation between liver cell dysplasia and hepatocellular carcinoma (HCC) is poorly understood. The aim of this study was to determine whether there is a genetic link between liver cell dysplasia and HCC that could support the role of dysplasia as a tumour precursor lesion.
METHODS: Microdissection from paraffin wax embedded sections and degenerate oligonucleotide primed polymerase chain reaction (DOP-PCR) were combined to analyse chromosomal imbalances by comparative genomic hybridisation (CGH) in nine HCCs and nodules containing liver cell dysplasia and cirrhosis adjacent to the tumours. Seven cases of large cell changes (LCC) and three cases of small cell changes (SCC) were analysed. The genetic abnormalities detected in liver cell dysplasia were then compared with those present in the corresponding HCC.
RESULTS: No abnormalities were detected in LCC and cirrhotic nodules, arguing against the preneoplasic nature of these cell foci. In contrast, a subset of chromosomal alterations present in HCCs was found in the adjacent SCC.
CONCLUSIONS: These findings support the preneoplastic status of SCC in human hepatocarcinogenesis.

Entities:  

Mesh:

Year:  2001        PMID: 11477144      PMCID: PMC1187080          DOI: 10.1136/mp.54.4.270

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  32 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

Review 2.  Terminology of nodular hepatocellular lesions.

Authors: 
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

3.  Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia.

Authors:  A Henmi; T Uchida; T Shikata
Journal:  Cancer       Date:  1985-06-01       Impact factor: 6.860

4.  Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients.

Authors:  C Cohen; S D Berson
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

5.  Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients.

Authors:  A Marchio; P Pineau; M Meddeb; B Terris; P Tiollais; A Bernheim; A Dejean
Journal:  Oncogene       Date:  2000-08-03       Impact factor: 9.867

6.  Liver cell dysplasia in cirrhosis. A serologic and immunohistochemical study.

Authors:  M Roncalli; M Borzio; G De Biagi; A R Ferrari; R Macchi; V M Tombesi; E Servida
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

7.  Liver cell dysplasia: a premalignant condition.

Authors:  P P Anthony; C L Vogel; L F Barker
Journal:  J Clin Pathol       Date:  1973-03       Impact factor: 3.411

8.  Abnormal DNA content in liver-cell dysplasia: a flow cytometric study.

Authors:  M Roncalli; M Borzio; B Brando; G Colloredo; E Servida
Journal:  Int J Cancer       Date:  1989-08-15       Impact factor: 7.396

9.  Morphologic studies of the liver cell dysplasia.

Authors:  S Watanabe; K Okita; T Harada; T Kodama; Y Numa; T Takemoto; T Takahashi
Journal:  Cancer       Date:  1983-06-15       Impact factor: 6.860

10.  Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma.

Authors:  G Akagi; K Furuya; A Kanamura; T Chihara; H Otsuka
Journal:  Cancer       Date:  1984-07-15       Impact factor: 6.860

View more
  7 in total

1.  Comparative genomic hybridisation as a supportive tool in diagnostic pathology.

Authors:  M M Weiss; E J Kuipers; S G M Meuwissen; P J van Diest; G A Meijer
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

2.  Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.

Authors:  Valeria R Mas; Daniel G Maluf; Kellie J Archer; Kenneth Yanek; Xiangrong Kong; Laura Kulik; Chris E Freise; Kim M Olthoff; Rafik M Ghobrial; Paula McIver; Robert Fisher
Journal:  Mol Med       Date:  2008-12-15       Impact factor: 6.354

Review 3.  Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges.

Authors:  Stavros C Efremidis; Prodromos Hytiroglou; Osamu Matsui
Journal:  Eur Radiol       Date:  2007-07-06       Impact factor: 5.315

4.  Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification.

Authors:  Kun Jiang; Sameer Al-Diffhala; Barbara A Centeno
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

Review 5.  Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma.

Authors:  Juliane Lokau; Victor Schoeder; Johannes Haybaeck; Christoph Garbers
Journal:  Cancers (Basel)       Date:  2019-11-01       Impact factor: 6.639

6.  Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis.

Authors:  Carolin Czauderna; Alicia Poplawski; Colm J O'Rourke; Darko Castven; Benjamín Pérez-Aguilar; Diana Becker; Stephanie Heilmann-Heimbach; Margarete Odenthal; Wafa Amer; Marcel Schmiel; Uta Drebber; Harald Binder; Dirk A Ridder; Mario Schindeldecker; Beate K Straub; Peter R Galle; Jesper B Andersen; Snorri S Thorgeirsson; Young Nyun Park; Jens U Marquardt
Journal:  JCI Insight       Date:  2021-09-08

Review 7.  Genetic alteration and gene expression modulation during cancer progression.

Authors:  Cathie Garnis; Timon P H Buys; Wan L Lam
Journal:  Mol Cancer       Date:  2004-03-22       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.